Webinar
Pairing Alloy Therapeutics’ best-in-class transgenic humanized mouse with Partillion Biosciences’ Nanovial technology provides a simple and cost-efficient method to perform high throughput screens of antibody secreting plasma cells for the discovery of antigen-specific antibodies. In this webinar, we demonstrate an antibody discovery workflow that yields diverse, high affinity binders with development potential in therapeutic settings.
Learn how:
ATX-Gx™ industry-leading humanized mouse models can be harnessed as in vivo human antibody discovery platform for generating a robust and diverse immune response
Nanovial technology can screen hundreds of thousands of fragile antibody-secreting plasma without the need for expensive instrumentation or lengthy workflows.
Plasma cells are a rich source of high affinity antibodies that have therapeutic potential